Biocon Biologics Receives Further Investment As Value Hits $3.5bn

Tata Capital Takes 0.85% Holding

 
• By Dean Rudge
  
Biocon_Magnified
Biocon has offloaded another sliver of equity in Biocon Biologics • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business